Article
Medicine, General & Internal
Ausvydas Patasius, Giedre Smailyte
Summary: This study in Lithuania on prostate cancer screening revealed that before screening, patients who were not screened had higher all-cause mortality risk, while those who were screened had similar all-cause mortality risk to the general population. Additionally, screened patients with localized stage of disease had lower all-cause mortality risk compared to the general population.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Gastroenterology & Hepatology
Dominika Bhatia, Rinku Sutradhar, Lawrence F. Paszat, Linda Rabeneck, Simron Singh, Jill Tinmouth, Lorraine L. Lipscombe
Summary: Individuals with comorbidities are less likely to receive colonoscopy after positive FOBT, indicating the need for better screening and follow-up strategies.
AMERICAN JOURNAL OF GASTROENTEROLOGY
(2022)
Article
Oncology
Nadine Zielonke, Lindy M. Kregting, Eveline A. M. Heijnsdijk, Piret Veerus, Sirpa Heinavaara, Martin McKee, Inge M. C. M. de Kok, Harry J. de Koning, Nicolien T. van Ravesteyn
Summary: The study found that if all European countries biennially screen all women aged 50 to 69 for breast cancer, despite the existing impact of breast cancer screening in Europe, there are still a significant number of breast cancer deaths that could be prevented. By increasing screening coverage, the breast cancer mortality rate in Europe can be substantially reduced.
INTERNATIONAL JOURNAL OF CANCER
(2021)
Article
Oncology
Ashley E. Burch, William D. Irish, Jan H. Wong
Summary: This study examines predictors of screening mammography use and its effect on breast cancer mortality in North Carolina. The results show that persistent poverty, college education, and health literacy score are associated with screening rates. However, these factors explain only a small percentage of variability, suggesting that advances in treatment may be the main contributor to improving breast cancer mortality.
BREAST CANCER RESEARCH AND TREATMENT
(2022)
Article
Medicine, General & Internal
M. Bretthauer, M. Loberg, P. Wieszczy, M. Kalager, L. Emilsson, K. Garborg, M. Rupinski, E. Dekker, M. Spaander, M. Bugajski, O. Holme, A. G. Zauber, N. D. Pilonis, A. Mroz, E. J. Kuipers, J. Shi, M. A. Hernan, H-O Adami, J. Regula, G. Hoff, M. F. Kaminski
Summary: This randomized trial found that participants who were invited to undergo screening colonoscopy had a lower risk of colorectal cancer within 10 years.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Oncology
Martin J. Yaffe, James G. Mainprize
Summary: Guidelines for breast cancer screening vary. A computer model was used to compare different screening regimens and found that annual screening starting from age 40 until age 74 can reduce breast cancer mortality and improve early detection, but it carries a risk of false positive results and negative biopsies.
Article
Medicine, General & Internal
M. Luke Marinovich, Elizabeth Wylie, William Lotter, Helen Lund, Andrew Waddell, Carolyn Madeley, Gavin Pereira, Nehmat Houssami
Summary: In this study, the accuracy of artificial intelligence (AI) was compared with radiologists in breast cancer screening. The AI algorithm showed a lower AUC compared to radiologists. However, AI detected interval cancers that were missed by radiologists.
Article
Oncology
Lilu Ding, Keris Poelhekken, Marcel J. W. Greuter, Inge Truyen, Harlinde De Schutter, Mathijs Goossens, Nehmat Houssami, Guido Van Hal, Geertruida H. de Bock
Summary: This study aimed to estimate the overdiagnosis rate of invasive breast cancer in an organised screening program, with results showing a higher overdiagnosis issue in older women and the importance of sufficient follow-up time for obtaining accurate estimates.
EUROPEAN JOURNAL OF CANCER
(2022)
Article
Oncology
Siqi Wu, Di Liang, Jin Shi, Daojuan Li, Yanyu Liu, Yahui Hao, Miaomiao Shi, Xinyu Du, Yutong He
Summary: This study investigated the participation and diagnostic yield of breast cancer screening in four cities in Hebei Province, China. The participation rate was 54.08%, and factors such as age, education level, menopausal status, smoking and alcohol consumption, family history of breast cancer, and benign breast disease were associated with participation. The screening group had a higher detection rate of breast cancer, especially for early stage and luminal A subtype.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2023)
Article
Oncology
Jeroen J. van den Broek, Clyde B. Schechter, Nicolien T. van Ravesteyn, A. Cecile J. W. Janssens, Michael C. Wolfson, Amy Trentham-Dietz, Jacques Simard, Douglas F. Easton, Jeanne S. Mandelblatt, Peter Kraft, Harry J. de Koning
Summary: Breast cancer family history and polygenic risk score can guide screening decisions for women aged 30-50 years. Combining family history and PRS has greater benefits in terms of life-years gained and breast cancer deaths averted compared to biennial screening from 50 to 74 years old.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
(2021)
Article
Medicine, General & Internal
Marc D. Ryser, Jane Lange, Lurdes Y. T. Inoue, Ellen S. O'Meara, Charlotte Gard, Diana L. Miglioretti, Jean-Luc Bulliard, Andrew F. Brouwer, E. Shelley Hwang, Ruth B. Etzioni
Summary: This study estimated the rate of breast cancer overdiagnosis in contemporary mammography practice, finding that about 1 in 7 cases of screen-detected cancer is overdiagnosed under biennial screening.
ANNALS OF INTERNAL MEDICINE
(2022)
Article
Oncology
Yi-Zi Zheng, Xian-Ming Wang, Lei Fan, Zhi-Ming Shao
Summary: This study found that for stage IV breast cancer, smaller primary tumors may not always be associated with better breast cancer-specific mortality. Particularly in triple-negative breast cancers (TNBCs), very small tumors with extensive regional lymph node involvement may indicate biologically aggressive disease.
Article
Oncology
Li C. Cheung, Kunnambath Ramadas, Richard Muwonge, Hormuzd A. Katki, Gigi Thomas, Barry Graubard, Partha Basu, Rengaswamy Sankaranarayanan, Thara Somanathan, Anil K. Chaturvedi
Summary: The study demonstrated the potential of risk-based oral cancer screening to enhance screening efficiency. Oral cancer screening significantly reduced oral cancer mortality rates, especially in high-risk individuals.
JOURNAL OF CLINICAL ONCOLOGY
(2021)
Article
Public, Environmental & Occupational Health
Elaheh Shoushtari-Moghaddam, Hossein Shahnazi, Akbar Hassanzadeh
Summary: The study aimed to provide breast cancer screening behavior training for female teachers in Isfahan, Iran. The results indicated that using the PEN-3 model in the educational intervention was effective in improving breast cancer screening behavior.
FRONTIERS IN PUBLIC HEALTH
(2023)
Article
Public, Environmental & Occupational Health
Matthew T. Keys, Miquel Serra-Burriel, Natalia Martinez-Lizaga, Maria Pellise, Francesc Balaguer, Ariadna Sanchez, Enrique Bernal-Delgado, Antoni Castells
Summary: The study found that FIT-based organized colorectal cancer screening in Spain was associated with a reduction in population colorectal cancer mortality. No differences in outcome trends were observed between exposed and control provinces in the 7 years prior to screening implementation. Two years after implementation, exposed provinces experienced an increase in colorectal cancer incidence, followed by a decrease in mortality rates after 7 years.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
(2021)